Ledger.Open graph →
SEC Form D · filed December 3, 2025

Protego Biopharma, Inc

Offering
$130.4M
Sold
$32.9M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Edward J. Hurwitz · SAN DIEGO, CADirectorJanwillem J. Naesens · SAN DIEGO, CADirectorLaura J. Brass · SAN DIEGO, CADirectorShelley J. Chu · Malvern, PADirectorHelen J. Kim · SAN DIEGO, CADirectorTim J. Lohoff · SAN DIEGO, CADirectorHank M. Petrassi · SAN DIEGO, CAExecSaoussen J. Ben Halima · SAN DIEGO, CADirectorJeffery J. Kelly · SAN DIEGO, CADirectorBrent J. Warner · San Diego, CAExec · DirectorHank M. Petrassi · SAN DIEGO, CAExecJanwillem J. Naesens · SAN DIEGO, CADirectorTim J. Lohoff · SAN DIEGO, CADirectorEdward J. Hurwitz · SAN DIEGO, CADirectorSaoussen J. Ben Halima · SAN DIEGO, CADirectorLaura J. Brass · SAN DIEGO, CADirectorJeffery J. Kelly · SAN DIEGO, CADirectorBrent J. Warner · San Diego, CAExec · DirectorShelley J. Chu · SAN DIEGO, CADirectorHelen J. Kim · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗